PMID: 7520269Jun 1, 1994Paper

TP53 alterations and clinical outcome in low grade astrocytomas

Genes, Chromosomes & Cancer
J A KrausU Schlegel

Abstract

Thirty-eight WHO grade II astrocytomas and 10 malignant recurrent gliomas in these patients were examined for the presence of TP53 alterations. Seventeen/38 low grade astrocytomas and 6/10 malignant recurrent tumors harbored mutations of the gene detected by SSCP analysis and direct sequencing of PCR products. TP53 mutations in five out of six high grade mutant tumors were already present in the corresponding low grade astrocytomas. In two cases, TP53 mutations present in the low grade astrocytoma could not be demonstrated in the recurrent glioma. Immunohistochemistry with two different antibodies to the human TP53 protein revealed nuclear immunoreaction of tumor cells in 11/38 low grade and in 8/10 recurrent tumors. There was no correlation between the presence of TP53 alteration and clinical course. We conclude that, although TP53 mutations are detectable in a substantial fraction of WHO grade II astrocytomas, they do not appear to play a role in the malignant progression of these tumors and they are not of prognostic significance.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Oct 1, 1992·Journal of Neuro-oncology·U SchlegelH Furneaux
Jan 1, 1992·Genes, Chromosomes & Cancer·C Caron de Fromentel, T Soussi
Oct 31, 1991·Biochemical and Biophysical Research Communications·Y HayashiK Yamaguchi
Jun 6, 1991·Nature·A J LevineC A Finlay
Jan 1, 1993·Journal of Neuropathology and Experimental Neurology·D N LouisB R Seizinger
Oct 1, 1993·The American Journal of Surgical Pathology·I SalmonR Kiss

❮ Previous
Next ❯

Citations

Sep 17, 1998·Genes, Chromosomes & Cancer·T J HulsebosE H Bijleveld
Apr 6, 2001·Seminars in Surgical Oncology·K K HerfarthJ Debus
Jun 1, 1996·Cancer Genetics and Cytogenetics·P CampomenosiG Fronza
Jul 10, 2003·Lancet Neurology·Peter H WesselsAlbert Twijnstra
Apr 13, 2011·Neurology India·Manish RanjanB A Chandramouli
Jul 29, 2011·Journal of Neuro-oncology·Marco GessiTorsten Pietsch
Nov 1, 1995·Glia·O BöglerW K Cavenee
Dec 1, 1995·Medical and Pediatric Oncology·C A FelixJ A Biegel
Jul 19, 2012·Journal of Neuropathology and Experimental Neurology·Kazuya MotomuraHiroko Ohgaki
Nov 7, 2003·Genes, Chromosomes & Cancer·Peter H WesselsAnton H N Hopman
Jun 8, 2012·Brain Pathology·Daniela PierscianekHiroko Ohgaki
Nov 16, 2010·Neuropathology and Applied Neurobiology·M GessiT Pietsch
Aug 17, 1999·Seminars in Cancer Biology·V P Collins
Feb 8, 2000·Cancer Treatment Reviews·C NiederH D Thames
Jan 10, 2001·Current Opinion in Neurology·J W Henson
Jul 3, 2003·British Journal of Cancer·P H WesselsA Twijnstra
Mar 5, 2014·Journal of Neuro-oncology·Emeline GilletAhmed Idbaih
Jun 28, 2005·Journal of Neuro-oncology·Chitra SarkarSubrata Sinha
Feb 15, 2001·Archives of Pathology & Laboratory Medicine·C Rodriguez-PereiraJ Forteza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.